In-silico drug repurposing and molecular dynamics puzzled out potential SARS-CoV-2 main protease inhibitors

MAA Ibrahim, AHM Abdelrahman… - Journal of biomolecular …, 2021 - Taylor & Francis
Herein, the DrugBank database which contains 10,036 approved and investigational drugs
was explored deeply for potential drugs that target SARS-CoV-2 main protease (Mpro) …

In-silico drug repurposing and molecular dynamics puzzled out potential SARS-CoV-2 main protease inhibitors

MAA Ibrahim, AHM Abdelrahman… - … structure & dynamics, 2021 - pubmed.ncbi.nlm.nih.gov
Herein, the DrugBank database which contains 10,036 approved and investigational drugs
was explored deeply for potential drugs that target SARS-CoV-2 main protease (M pro) …

In-silico drug repurposing and molecular dynamics puzzled out potential SARS-CoV-2 main protease inhibitors

MAA Ibrahim, AHM Abdelrahman… - Journal of …, 2021 - ingentaconnect.com
Herein, the DrugBank database which contains 10,036 approved and investigational drugs
was explored deeply for potential drugs that target SARS-CoV-2 main protease (Mpro) …

[引用][C] In-silico drug repurposing and molecular dynamics puzzled out potential SARS-CoV-2 main protease inhibitors

MAA Ibrahim, AHM Abdelrahman… - Journal of Biomolecular …, 2020 - cir.nii.ac.jp
<i>In-silico</i> drug repurposing and molecular dynamics puzzled out potential SARS-CoV-2
main protease inhibitors | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …

In-silico drug repurposing and molecular dynamics puzzled out potential SARS-CoV-2 main protease inhibitors.

MAA Ibrahim, AHM Abdelrahman… - Journal of Biomolecular …, 2020 - europepmc.org
Herein, the DrugBank database which contains 10,036 approved and investigational drugs
was explored deeply for potential drugs that target SARS-CoV-2 main protease (M pro) …

[PDF][PDF] In-silico drug repurposing and molecular dynamics puzzled out potential SARS-CoV-2 main protease inhibitors

MAA Ibrahim, AHM Abdelrahman, F Mohamed-Elamir - researchgate.net
Herein, the DrugBank database which contains 10,036 approved and investigational drugs
was explored deeply for potential drugs that target SARS-CoV-2 main protease (Mpro) …

[HTML][HTML] In-silico drug repurposing and molecular dynamics puzzled out potential SARS-CoV-2 main protease inhibitors

MAA Ibrahim, AHM Abdelrahman… - Journal of Biomolecular …, 2020 - ncbi.nlm.nih.gov
Herein, the DrugBank database which contains 10,036 approved and investigational drugs
was explored deeply for potential drugs that target SARS-CoV-2 main protease (M pro) …